Member info
Dr Laura Mauring
Substitute
Estonia
Working Group(s): Retinal Rare Eye Diseases (WG1), Pediatric Ophthalmology Rare Diseases (WG3), Genetic Diagnostics (TWG6)
Team
HCP Center
Tartu University Hospital is the largest health care provider in Estonia. High quality tertiary medical care is offered in nearly all...
contact
Clinical trials
NCT04435366 Completed
A Phase 3 Multicenter, Randomized, Double Masked, Sham- Controlled Clinical Trial to Assess the Safety and Efficacy of Intravitreal Administration of Zimura (Complement C5 Inhibitor) in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Interventional
NCT04423718 Active, Not recruiting
Randomized, Double-Masked, Active-Controlled, Phase 3 Study of the Efficacy and Safety of High Dose Aflibercept in Patients With Neovascular Age-Related Macular Degeneration
Interventional
NCT04270747 Completed
A Randomized, Double-masked, Phase 3 Study of ABP 938 Efficacy and Safety Compared to Aflibercept (Eylea®) in Subjects With Neovascular Age-related Macular Degeneration
Interventional
NCT04939571 Recruiting, Active
European Disease Registry on Retinopathy of Prematurity (ROP)
Observational